While all drugs sold to American consumers face a rigorous approval process, that’s not the case when it comes to supplements. The Food and Drug Administration (FDA) does not approve supplements, and while there are Read more…
AUD/USD’s rally continues today and intraday bias stays on the upside for retesting 0.7277 high. Decisive break there will confirm larger up trend resumption. On the downside, below 0.7172 minor support will turn intraday bias Read more…
Intraday bias in USD/CAD remains neutral at this point. Prior rejection at 38.2% retracement of 1.4247 to 1.3730 at 1.3927 suggests that fall from 1.4247 is still in progress. On the downside, break of 1.3730 Read more…
GBP/JPY’s fall continues today and breaks through 209.55 support. Current decline is part of the corrective pattern from 219.56. Intraday bias stays on the downside for 206.10 fibonacci level. On the upside, above 211.79 minor Read more…
EUR/JPY’s fall continues today and broke 179.34 support. Intraday bias remains on the downside. Current decline is part of the corrective pattern from 187.93. Sustained trading below 179.34 will pave the way to 175.41 key Read more…
Intraday bias in EUR/GBP remains neutral at this point. Outlook is unchanged that rebound from 0.8453 is seen as a corrective move. Upside should be limited by 0.8610 support turned resistance. Break of 0.8545 will Read more…
Intraday bias in EUR/AUD stays on the downside for the moment. Decisive break of 1.6108 low will resume the whole down trend from 1.8554 high. Next target is 1.5359 projection level. On the upside, above Read more…
EUR/CHF is extending consolidations below 0.9434 and intraday bias remains neutral. Initial bias remains neutral this week for consolidations. Further rise is expected as long as 0.9304 support holds. Above 0.9434 will resume the while Read more…
TheStreet aims to feature only the best products and services. If you buy something via one of our links, we may earn a commission. Why we love this deal As fall approaches, the earlier sunsets Read more…
Cathie Wood, chief of Ark Investment Management, often adds to her favorite stocks when prices swing. This time, according to an email shared with TheStreet, she’s buying $3.5 million of Robinhood stock, reversing her recent Read more…